Meagan Wilson
General Practice · Dawsonville, GANPI 1881140598
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 408 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 54 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Among general practice clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 408 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$597
- Otsuka America Pharmaceutical, Inc.$480
- Novo Nordisk$458
- Pfizer$266
- Novartis$251
- plus $4K from 48 others
What the payments were for
- Food & beverage$6,824100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,854 in reported general payments places this provider in the 95th percentile of 2,542 general practice providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $58,005 |
| FarxigaDapagliflozin Propanediol | 43 | $29,037 |
| MounjaroTirzepatide | 26 | $27,038 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $26,340 |
| TrulicityDulaglutide | 26 | $24,093 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $19,922 |
| Repatha SureclickEvolocumab | 22 | $17,110 |
| VascepaIcosapent Ethyl | 21 | $11,943 |
| Repatha SyringeEvolocumab | 18 | $11,003 |
| LinzessLinaclotide | 16 | $10,973 |
| Emgality SyringeGalcanezumab-Gnlm | 11 | $7,817 |
| TrintellixVortioxetine Hydrobromide | 16 | $7,628 |
| BelsomraSuvorexant | 16 | $7,135 |
| MyrbetriqMirabegron | 16 | $7,091 |
| Ibuprofen-FamotidineIbuprofen/Famotidine | 17 | $3,718 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $458 | $58,00554 claims |
| Lilly USA, LLCMounjaro, Trulicity | $225 | $51,13152 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $112 | $48,95968 claims |
| GSKTrelegy Ellipta, Shingrix | $207 | $28,94149 claims |
| AbbVieLinzess | $1,222 | $10,97316 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $152 | $7,62816 claims |
| MerckBelsomra | $75 | $7,13516 claims |
| Astellas Pharma US IncMyrbetriq | $49 | $7,09116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,542 general practice providers in Georgia.
Other general practice in Dawsonville
- Edward SchlisselMarietta$665K
- Peter VanstromTucker$424K
- Robert PauleyUnion City$155K
- Stanton McKennaAtlanta$75K
- Carlos TanGainesville$75K
- Michael BoydAugusta$67K
- Harris SiegelAtlanta$54K
- John ComisiAugusta$50K
- Jeffery BradleyLithia Springs$45K
- Ushma PatelSuwanee$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.